-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
There were no US Food and Drug Administration Board approved for the treatment of newbornmedsci.
managementmedsci.
A total of 83 newborns were included in the study, and they were randomly divided into the phenobarbital treatment group and the levetiracetam treatment group.
The results showed that 80% (24 persons) of neonates in the phenobarbital group had no seizures within 24 hours, and 28% (15 persons) of the levetiracetam group had no seizures (P<0.
In summary, in this phase IIb study, phenobarbital was more effective than levetiracetam in treating neonatal seizures.
Original source:
Cynthia Sharpe, et al.
ncbi.
nlm.
nih.
gov/32385134/" target="_blank" rel="noopener">Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial in this message